PO.TB10.08 · 肿瘤生物学
高多重空间成像揭示乳腺肿瘤微环境中细胞类型特异性的脂肪因子信号网络
Cell type-specific adipokine signaling networks in the breast tumor microenvironment uncovered by high-plex spatial imaging
该海报暂无可下载的资料
AACR 官方页面
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
背景:肥胖与不良的乳腺癌结局相关,但连接脂肪信号与肿瘤进展的机制仍不清楚。脂肪因子如瘦素(leptin)和脂联素(adiponectin)及其受体,可能通过乳腺肿瘤微环境(TME)中肿瘤、基质和免疫细胞间的旁分泌和自分泌相互作用影响肿瘤行为。我们使用高多重空间分子成像,绘制脂肪因子表达和细胞类型特异性信号网络的图谱,以揭示与肥胖相关的肿瘤生物学差异。
方法:使用CosMx空间分子成像仪(Human 6K Panel)对乳腺肿瘤及配对邻近组织进行单细胞空间转录组学分析。通过AI框架将细胞分割并分类为肿瘤上皮、基质和免疫区室。定量检测LEP、LEPR、ADIPOQ、ADIPOR1和ADIPOR2,以得出区室特异性阳性率、平均/极高表达、潜在的5基因共表达以及复合脂肪因子特征评分,并将其表达与非肿瘤细胞和邻近组织细胞进行比较,并与所选临床变量相关联。
结果:在259名II-III期乳腺癌女性中(49%绝经后,47%黑人,53%西班牙裔,62% ER阳性,17% HER2阳性),脂肪因子及受体表达在肿瘤细胞中始终高于基质或免疫细胞。所有五个肥胖相关基因在肿瘤细胞中的表达均高于基质和免疫细胞。在肿瘤上皮区室中,ADIPOR1、ADIPOR2和LEPR相较于邻近上皮表现出显著的高端表达(P<10⁻¹⁶),定义了一个肿瘤内在的脂肪因子受体程序。肿瘤上皮的5基因特征评分和≥2个脂肪因子基因的共表达在一部分肿瘤中富集,并与肿瘤大小呈适度负相关。在基质中,ADIPOR1、ADIPOR2和LEPR形成一个紧密协调的模块;基质ADIPOR1阳性和较高的基质脂肪因子特征评分在更高级别和ER阴性肿瘤中富集,提示存在一种与级别和亚型相关的基质脂肪因子表型。在免疫区室中,ADIPOR1和ADIPOR2以较低强度广泛可检测,与LEPR和免疫特异性脂肪因子评分相关,符合一个独特的免疫聚焦轴。跨区室中,5基因特征捕获了在肿瘤与邻近组织之间被重塑的、连贯的全TME脂肪因子程序,并显示出与BMI、级别、ER状态和肿瘤大小的区室特异性关联。
结论:单细胞空间谱分析揭示了乳腺TME中一种区室化的脂肪因子结构,包括增强的肿瘤上皮受体程序、与级别相关的基质模块以及免疫相关轴,它们共同构成整合的脂肪因子特征,与临床病理特征密切相关。
查看英文原文 English abstract
Background Adiposity is linked to adverse breast cancer outcomes, but mechanisms connecting adipose signaling to tumor progression remain unclear. Adipokines like leptin and adiponectin, and their receptors, may influence tumor behavior via paracrine and autocrine interactions across tumor, stromal, and immune cells in the breast tumor microenvironment (TME). Using high-plex spatial molecular imaging, we mapped adipokine expression and cell type-specific signaling networks to reveal adiposity-related differences in tumor biology.
Methods Single-cell spatial transcriptomics was performed using the CosMx Spatial Molecular Imager (Human 6K Panel) on breast tumors and matched adjacent tissues. Cells were segmented and classified into tumor epithelium, stroma, and immune compartments via an AI framework. LEP, LEPR, ADIPOQ, ADIPOR1, and ADIPOR2 were quantified to derive compartment-specific positivity rates, mean/very high expression, potential 5-gene co-expression, and composite adipokine signature scores and expression was compared with non-tumor cells and cells from adjacent tissues, and correlated with select clinical variables.
Results In 259 women with stage II-III breast cancer (49% postmenopausal, 47% Black, 53% Hispanic, 62% ER-positive, 17% HER2-positive), adipokine and receptor expression was consistently higher in tumor cells than stromal or immune cells. All five adiposity genes showed elevated expression in tumor cells versus stroma and immune cells. In the tumor epithelial compartment, ADIPOR1, ADIPOR2, and LEPR exhibited markedly high-end expression versus adjacent epithelium (P <10⁻¹⁶), defining a tumor-intrinsic adipokine receptor program. Tumor epithelial 5-gene signature scores and co-expression of ≥2 adipokine genes were enriched in a subset of tumors and modestly inversely associated with tumor size. In stroma, ADIPOR1, ADIPOR2, and LEPR formed a tightly coordinated module; stromal ADIPOR1 positivity and higher stromal adipokine signature scores were enriched in higher-grade and ER-negative tumors, indicating a grade- and subtype-linked stromal adipokine phenotype. In the immune compartment, ADIPOR1 and ADIPOR2 were broadly detectable at lower intensity, correlated with LEPR and immune-specific adipokine scores, consistent with a distinct immune-focused axis. Across compartments, 5-gene signatures captured coherent TME-wide adipokine programs remodeled in tumor versus adjacent tissue and showing compartment-specific associations with BMI, grade, ER status, and tumor size.
Conclusion Single-cell spatial profiling reveals a compartmentalized adipokine architecture in the breast TME, including a heightened tumor epithelial receptor program, a grade-linked stromal module, and an immune-associated axis that together form integrated adipokine signatures strongly connected to clinicopathologic features.
利益披露 Disclosure
A. Rockson, None..
H. Hibshoosh, None..
P. Shah, None..
F. Derakhshan, None..
D. Chen, None..
A. Salem, None..
D. Fernandez, None..
A. L. Castillo, None..
E. Armstrong, None..
I. Anyene Fumagalli, None..
S. K. Singhal, None..
A. A. Llanos, None.